Literature DB >> 10960621

Histologic chorioamnionitis, antenatal steroids, and perinatal outcomes.

A Elimian1, U Verma, D Beneck, R Cipriano, P Visintainer, N Tejani.   

Abstract

OBJECTIVE: To determine the perinatal effects of histologic chorioamnionitis on preterm neonates and the effectiveness of antenatal steroids in the presence of histologic chorioamnionitis.
METHODS: We studied neonates at our institution who weighed 1750 g or less at birth from January 1990 through December 1997. The population was stratified primarily by presence of histologic chorioamnionitis and secondarily by exposure to antenatal steroids. Subgroups were compared by various perinatal outcomes and confounding variables. Student t test, chi(2), Fisher exact test, and logistic regression were used for analysis.
RESULTS: Among 1260 neonates entered, the placentas of 527 had evidence of histologic chorioamnionitis and 733 did not. Those with histologic chorioamnionitis had a lower mean gestational age, lower birth weight, and higher rate of major neonatal morbidities than those without it. After adjusting for confounding variables, histologic chorioamnionitis independently associated with lower gestational age, lower birth weight, and neonatal death. Among neonates exposed to antenatal steroids who had histologic chorioamnionitis, there was a significantly lower incidence of low Apgar scores (18% compared with 33.5%, P <.001), respiratory distress syndrome (RDS) (39.6% compared with 55.9%, P <.001), intraventricular hemorrhage and periventricular leukomalacia (21.9% compared with 36.9%, P <.001), major brain lesions (7.7% compared with 18.4%, P <.001), patent ductus arteriosus (14.8% compared with 23.7%, P =.018), and neonatal death (8.3% compared with 16.2%, P =.02), with no increase in rate of proven neonatal sepsis (18.3% compared with 14%, P =.24).
CONCLUSION: Histologic chorioamnionitis increases major perinatal morbidity through its association with preterm birth and is independently associated with neonatal death. In the presence of histologic chorioamnionitis, antenatal steroids significantly decreased the incidence of RDS, intraventricular hemorrhage and periventricular leukomalacia, major brain lesions, and neonatal mortality, without increasing neonatal sepsis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10960621     DOI: 10.1016/s0029-7844(00)00928-5

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  27 in total

1.  A point of care test for interleukin-6 in amniotic fluid in preterm prelabor rupture of membranes: a step toward the early treatment of acute intra-amniotic inflammation/infection.

Authors:  Piya Chaemsaithong; Roberto Romero; Steven J Korzeniewski; Alicia Martinez-Varea; Zhong Dong; Bo Hyun Yoon; Sonia S Hassan; Tinnakorn Chaiworapongsa; Lami Yeo
Journal:  J Matern Fetal Neonatal Med       Date:  2015-03-23

Review 2.  Targeting inflammation to prevent bronchopulmonary dysplasia: can new insights be translated into therapies?

Authors:  Clyde J Wright; Haresh Kirpalani
Journal:  Pediatrics       Date:  2011-06-06       Impact factor: 7.124

3.  The relationship between the intensity of intra-amniotic inflammation and the presence and severity of acute histologic chorioamnionitis in preterm gestation.

Authors:  Sun Min Kim; Roberto Romero; Jeong Woo Park; Kyung Joon Oh; Jong Kwan Jun; Bo Hyun Yoon
Journal:  J Matern Fetal Neonatal Med       Date:  2014-10-20

4.  Chorioamnionitis and Culture-Confirmed, Early-Onset Neonatal Infections.

Authors:  Jonathan M Wortham; Nellie I Hansen; Stephanie J Schrag; Ellen Hale; Krisa Van Meurs; Pablo J Sánchez; Joseph B Cantey; Roger Faix; Brenda Poindexter; Ronald Goldberg; Matthew Bizzarro; Ivan Frantz; Abhik Das; William E Benitz; Andi L Shane; Rosemary Higgins; Barbara J Stoll
Journal:  Pediatrics       Date:  2015-12-30       Impact factor: 7.124

Review 5.  Controversy: antenatal steroids.

Authors:  Ronald Wapner; Alan H Jobe
Journal:  Clin Perinatol       Date:  2011-09       Impact factor: 3.430

6.  Identification and H(2)O(2) production of vaginal lactobacilli from pregnant women at high risk of preterm birth and relation with outcome.

Authors:  Mark Wilks; Rebecca Wiggins; Angela Whiley; Enid Hennessy; Simon Warwick; Helen Porter; Anthony Corfield; Michael Millar
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

7.  Prenatal inflammation and lung development.

Authors:  Boris W Kramer; Suhas Kallapur; John Newnham; Alan H Jobe
Journal:  Semin Fetal Neonatal Med       Date:  2008-10-08       Impact factor: 3.926

Review 8.  Management of clinical chorioamnionitis: an evidence-based approach.

Authors:  Agustin Conde-Agudelo; Roberto Romero; Eun Jung Jung; Ángel José Garcia Sánchez
Journal:  Am J Obstet Gynecol       Date:  2020-09-29       Impact factor: 8.661

9.  Perinatal Outcome in Pregnancies with Extreme Preterm Premature Rupture of Membranes (Mid-Trimester PROM).

Authors:  Nihal Al-Riyami; Fatma Al-Shezawi; Intisar Al-Ruheili; Tamima Al-Dughaishi; Murtadha Al-Khabori
Journal:  Sultan Qaboos Univ Med J       Date:  2013-02-27

10.  Association of chorioamnionitis and patent ductus arteriosus in a national U.S. cohort.

Authors:  Celeste A Green; Daniel Westreich; Matthew M Laughon; David M Stamilio; Robert A Strauss; Jeff Reese; Elaine L Shelton; Kartik K Venkatesh
Journal:  J Perinatol       Date:  2020-10-22       Impact factor: 2.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.